Literature DB >> 16048554

Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.

Charles O Elson1, Yingzi Cong, Vance J McCracken, Reed A Dimmitt, Robin G Lorenz, Casey T Weaver.   

Abstract

There are now many experimental models of inflammatory bowel disease (IBD), most of which are due to induced mutations in mice that result in an impaired homeostasis with the intestinal microbiota. These models can be clustered into several broad categories that, in turn, define the crucial cellular and molecular mechanisms of host microbial interactions in the intestine. The first of these components is innate immunity defined broadly to include both myeloid and epithelial cell mechanisms. A second component is the effector response of the adaptive immune system, which, in most instances, comprises the CD4+ T cell and its relevant cytokines. The third component is regulation, which can involve multiple cell types, but again particularly involves CD4+ T cells. Severe impairment of a single component can result in disease, but many models demonstrate milder defects in more than one component. The same is true for both spontaneous models of IBD, C3H/HeJBir and SAMPI/Yit mice. The thesis is advanced that 'multiple hits' or defects in these interacting components is required for IBD to occur in both mouse and human.

Entities:  

Mesh:

Year:  2005        PMID: 16048554     DOI: 10.1111/j.0105-2896.2005.00291.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  187 in total

Review 1.  Contributions of the intestinal microbiome in lung immunity.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Eur J Immunol       Date:  2017-08-31       Impact factor: 5.532

2.  The role of oral hygiene in inflammatory bowel disease.

Authors:  Shashideep Singhal; Delia Dian; Ali Keshavarzian; Louis Fogg; Jeremy Z Fields; Ashkan Farhadi
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

Review 3.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 4.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 5.  Gut microbiota and related diseases: clinical features.

Authors:  Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

Review 6.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

7.  Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.

Authors:  Deanna D Nguyen; Michel H Maillard; Vinicius Cotta-de-Almeida; Emiko Mizoguchi; Christoph Klein; Ivan Fuss; Cathryn Nagler; Atsushi Mizoguchi; Atul K Bhan; Scott B Snapper
Journal:  Gastroenterology       Date:  2007-07-12       Impact factor: 22.682

8.  Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies.

Authors:  E C Ebert; A Panja; K M Das; R Praveen; X Geng; C Rezac; M Bajpai
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis.

Authors:  Lauren E Ritchie; Joseph M Sturino; Raymond J Carroll; Lloyd W Rooney; M Andrea Azcarate-Peril; Nancy D Turner
Journal:  FEMS Microbiol Ecol       Date:  2015-01-14       Impact factor: 4.194

10.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.